Dosage regimens of LINGO-1 antagonists and their uses for the treatment of demyelinating disorders

MA45668AUndetermined Publication Date: 2019-05-22BIOGEN MA INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MA45668
Authority / Receiving Office
MA · MA
Patent Type
Applications
Current Assignee / Owner
Priority Date
2017-05-30
Filing Date
2017-07-12
Publication Date
2019-05-22
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.